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Chagas disease, produced by the protozoan Trypanosoma cruzi (T. cruzi), is one of the most frequent endemic diseases in Latin
America. In spite the fact that in the past few years T. cruzi congenital transmission has become of epidemiological importance,
studies about this mechanism of infection are scarce. In order to explore some morphological aspects of this infection in the
placenta, we analyzed placentas from T. cruzi-infected mothers by immunohistochemical and histochemical methods. Infection
in mothers, newborns, and placentas was conﬁrmed by PCR and by immunoﬂuorescence in the placenta. T. cruzi-infected pla-
centas present destruction of the syncytiotrophoblast and villous stroma, selective disorganization of the basal lamina, and disor-
ganization of collagen I in villous stroma. Our results suggest that the parasite induces reorganization of this tissue component and
in this way may regulate both inﬂammatory and immune responses in the host. Changes in the ECM of placental tissues, together
with the immunological status of mother and fetus, and parasite load may determine the probability of congenital transmission of
T. cruzi.
1.Introduction
American Trypanosomiasis, or Chagas disease, is a zoonosis
caused by Trypanosoma cruzi (T. cruzi). Currently, 10 million
people in the Americas, from Mexico in the north to
ArgentinaandChileinthesouth,areestimatedtobeinfected
[1]. For thousands of years, Chagas disease was known only
in the Region of the Americas, mainly in Latin America,
where it has been endemic [2]. In past decades, it has been
increasingly detected in other non-endemic countries in
the American (Canada and the United States), the Western
Paciﬁc(mainlyAustraliaandJapan)and theEuropeanconti-
nents. The presence of Chagas disease outside Latin America
is the result of population mobility, notably migration, but
cases have been reported among travelers returning from
L a t i nA m e r i c aa n de v e ni na d o p t e dc h i l d r e n[ 3]. Subsequent
transmission occurs through transfusion, vertical, and trans-
plantation routes [3].
Theverticaltransmissionof T.cruzicannotbeprevented,
but early detection and treatment of congenital infection
achieves cure rates close to 100 per cent [4].
Fetal and maternal tissues are separated by a fetal epithe-
lium (the trophoblast), the greatest area of which is in the
villous placenta, the site of nutrient and gas exchange [5].
Thehumanplacentaisclassiﬁedasahemochorialvillouspla-
centainwhichthefreechorionicvilliarethefunctionalunits.2 Journal of Tropical Medicine
These chorionic villi are formed by the trophoblast and the
villous stroma. The trophoblast is formed by a single mul-
tinucleated cell layer (syncytiotrophoblast) which contacts
maternal blood in the intervillous space, and by the cytotro-
phoblast which contains replicating progenitor cells. The
trophoblast is separated by a basal lamina from the villous
stroma, which is connective tissue containing vascular endo-
thelium,ﬁbroblasts,andmacrophages[5].Trophoblast,basal
laminae, and villous stroma with endothelium of fetal cap-
illaries form the placental barrier that must be crossed by
diﬀerent pathogens, including T. cruzi, in order to infect the
fetus during vertical transmission [6, 7].
Damage to the villous placenta is almost always accom-
panied by inﬂammation, either in the intervillous space or
within the fetal villi, and in severe cases is accompanied by
lossoftheprotectivetrophoblast.Extensiveplacentaldamage
may lead to fetal loss, intrauterine growth retardation [5],
andclinicalmanifestationsthatcanbeobservedinacutecon-
genital Chagas disease [8, 9].
We have previously demonstrated that T. cruzi induces
syncytiotrophoblast destruction and detachment in chori-
onicvilliexplants,andselectivedisorganization ofbasallam-
ina and disorganization of collagen I in the connective tissue
of villous stroma [6]. However, no studies observing similar
histopathological alterations in the diﬀerent tissue compart-
ments of chorionic villi from placentas of mothers with
Chagas disease have been reported.
The aim of the present study was to determine whether
the tissue disorganization and destruction of chorionic villi,
described previously in ex vivo infected chorionic villi ex-
plants, can also be observed in placentas from Chagasic
women. The diagnosis of Chagas disease in the women stud-
ied was performed by standard serological testing and PCR.
Additionally, the parasite was detected in the placenta by
immunoﬂuorescence and PCR. Histopathological analysis,
immunohistochemical studies of basal lamina, and histo-
chemical studies of carbohydrate-rich molecules and colla-
gen I in villous stroma of these placentas were performed.
2.MaterialandMethods
2.1. Patients and Diagnosis of T. cruzi Infection. Three preg-
nant women with asymptomatic Chagas disease were en-
rolled from the hospitals of Illapel, Servicio de Salud de
Coquimbo, IV Region of Chile. Informed consent for the
experimental use of the placentas was given by each patient
as stipulated by the Code of Ethics of the Faculty of Medicine
of the University of Chile. Maternal T. cruzi infection
was assessed by standard serological techniques and PCR
(Figure 1(a) and Table 1). T. cruzi infection in neonates was
diagnosed by detection of parasites in umbilical cord or in
peripheral blood by microscopic examination using hep-
arinized microhematocrite tubes and PCR (Figure 1(a) and
Table 1). All of the neonates were negative for the presence
of the parasite by direct parasitological examination. Two
mothers and their respective newborns were positive for
parasite DNA detection by PCR (Figure 1 lines 5 & 7 and
8 & 10), the third mother and her newborn were negative
for parasite DNA detection by PCR (Figure 1 lines 11 & 13).
MW 1 2 3 4 5 6 7 8 9 10 11 12 13
400pd
300pd
Figure 1: Detection of T. cruzi in mother, newborn, and placenta by
PCR: A 330-base pair fragment of the T. cruzi satellite DNA was
ampliﬁed as described in Material and Methods. MW: molecular
marker, lane 1: Negative control without DNA; lane 2: DNA from T.
cruzi epimastigotes; lane 3: noninfected human blood DNA; lane
4 non-infected human placenta DNA; lanes 5–7: parasite DNA
detected in peripheral blood (lane 5), in placenta (lane 6), and
respective umbilical chord from neonate (lane 7) of mother 1;
lanes 8–10: parasite DNA detected in peripheral blood (lane 8), in
placenta (lane 9), and respective umbilical cord from neonate (lane
10) of mother 2; lanes 11–13: parasite DNA detected in peripheral
blood(lane11),inplacenta(lane12)andrespectiveumbilicalchord
from neonate (lane 13) of mother 3. Note that in mother 3 parasite
DNA can only be detected in the placenta. The PCR product was
subjected to electrophoresis in 1.6% agarose gels and stained with
ethidium bromide. PCR markers from Promega were employed as
molecular weight standards.
Nevertheless, this last mother was positive using standard se-
rologicaltechniques.Gestationalagewasdeterminedbyclin-
icaland ultrasoundanalysis.Clinical data ofthe mothers and
newborns are shown in Table 1.
For parasite DNA detection by PCR, a 330-base pair
fragment of the T. cruzi satellite DNA was ampliﬁed as
described previously [10]. The sequence of the oligonu-
cleotides is the following: forward (5-AAATAATGTACG-
G(T/G)GAGATGCATGA-3, speciﬁc primer 121) and back-
ward (5-GGTTCGATTGGGGTTGGTGTAATATA-3 speciﬁc
primer122).ThePCRproductwassubjectedtoelectrophore-
sis in 1.6% agarose gels and stained with ethidium bromide.
PCR markers from Promega were employed as molecular
weight standards [10].
2.2. Placentas. We used three placentas from asymptomatic
chagasicwomen.Placentasfromcontrolhealthywomenwere
obtained from vaginal or caesarean deliveries of uncompli-
cated pregnancies from the Hospital San Jos´ e, Servicio de
Salud Norte; Region Metropolitana, Santiago, Chile. Exclu-
sion criteria for the control placentas were the following:
major fetal abnormalities, placental tumor, intrauterine in-
fection, obstetric pathology, and any other maternal disease.
Villous tissue was obtained from the central part of cotyle-
dons and immediately ﬁxed in 10% formaldehyde in 0.1M
phosphate buﬀer (pH 7.3) for 24 hours.
2.3. Histological and Histochemical Techniques. The ﬁxed tis-
sues were dehydrated in alcohol, clariﬁed in xylene, embed-
ded in paraﬃn, and sectioned at 5μm. Paraﬃn-embedded
histological sections that were stained with hematoxylin-
eosin for routine histological analysis, Picrosirius red-
hematoxylin [6] and Arteta [11] for collagen histochemistry,
and periodic acid-Schiﬀ (PAS) for carbohydrate containing
tissue elements (Sigma-Aldrich kit 395B) were applied.Journal of Tropical Medicine 3
Table 1: Characterization of clinical features of mothers and neonates.
Mother 1 Mother 2 Mother 3
Age mother (years) 43 32 39
Gestational age (weeks) 38 36 40
Type of delivery Vaginal Cesarean Vaginal
Birth weight (g) 2880 2690 3550
APGAR 5min 9.9 9.9 9.9
Chagas’ disease diagnosis of the mother ELISA/IFI + ELISA/IFI + ELISA/IFI +
Detection of the parasite in the neonate by direct parasitological examination Negative Negative Negative
Detection of the parasite in the mother by PCR Positive Positive Negative
Detection of the parasite in the neonate by PCR Positive Positive Negative
Detection of the parasite in the placenta by PCR Positive Positive Positive
As a control of PAS method, 5μm-thick sections were
incubated with a 4μg/mL solution of α-amylase (Nutritional
Biochemical Corporation) in PBS pH 6.0, for 30 minutes at
37◦C prior to the PAS reaction (data not shown). A decrease
in the intensity of the PAS stain reaction after the enzyme
treatment was considered as evidence for the presence of
glycosylated molecules [11].
2.4. Immunohistochemistry. The placental chorionic villi
were ﬁxed, dehydrated, and embedded in paraﬃna sd e -
scribed above. Standard immunoperoxidase techniques were
used to show collagen IV, heparan sulphate and ﬁbronectin.
The primary antibodies were applied individually to each
section at 4◦C overnight (anti-collagen IV Novocastra NCL-
COLL-IV, dilution 1:100v/v; anti-heparan sulphate Novo-
castraNCL-CD44-2,dilution1:40v/v;anti-ﬁbronectinABR
MA1-83176, dilution 1:50v/v). Immunostaining was per-
formed using a horseradish peroxidase-labelled streptavidin
biotin kit (RTU-Vectastain kit) following the manufac-
turer’s directions using diaminobenzidine as the chromogen.
Sections were counterstained with Mayer’s haematoxylin
(DAKO) and mounted with Entellan (Merck). Immunohis-
tochemical controls were performed by replacing the pri-
mary antibodies with phosphate buﬀered saline. All con-
trols were negative. All sections were examined by light
microscopy (Leitz Orthoplan), and images were captured
with a Canon 1256 camera.
2.5. Detection of T. cruzi in Placental Tissue. T. cruzi invasion
was observed by immunoﬂuorescence and by parasite DNA
detection using the polymerase chain reaction (PCR).
Immunoﬂuorescence. Theplacentalchorionicvilliwereﬁxed,
dehydrated, and embedded in paraﬃn as described above. A
monoclonal antibody (mAb 25, dilution 1:100v/v) speciﬁc
for the T. cruzi ﬂagellar calcium-binding protein (a gift from
Dr. Schenkman, Universidade de Sao Paulo, Sao Paulo,
Brasil) was applied to each section overnight at 4◦C. The
preparations werewashedwithPBSand incubated withanti-
mouse IgG conjugated with ﬂuorescein (ScyTek, ACA) in
the presence of 1μg/mL of 4 6 diamidino-2-phenylindole
(DAPI). Afterwards, sections were mounted in VectaShield
(ScyTek, ACA) and observed in a Nikon Eclipse E400 micro-
scope (Tokio, Japan).
PCR. Genomic DNA that was extracted from the paraf-
ﬁn included placental tissue with the NucleoSpin Tissue
kit (Machery-Nagel) according manufacturer’s instructions.
ThesamesatelliteDNAfragmentofT.cruzi,usedforparasite
detection in blood of mother and child (see above), was
ampliﬁed.
3. Results
3.1. T. cruzi Detection in Mothers, Newborns, and Placentas.
ThediagnosisofChagasdiseaseofthethreemothersenrolled
in our study was performed by standard serological tech-
niques. After delivery, blood samples from the mothers and
umbilical cords from respective neonates were processed for
parasiteDNAdetectionbyPCR(Figure 1lines5&7(mother
& neonate 1), 8 & 10 (mother & neonate 2), 11 & 13 (mother
& neonate 3)). DNA from the placentas was obtained from
formalin-ﬁxed placental tissue samples (Figure 1 lines 6, 9
and 12 show the results from placentas from mother 1, 2,
and 3, resp.). Interestingly, one of the mothers (mother 3)
and her newborn were negative for PCR (Figure 1 lines 11
and 13) but the placenta was positive (Figure 1 line 12).
The negative result for parasitic DNA detection by PCR
in this mother and newborn may be due to a very low
parasitemia, characteristic in the asymptomatic and chronic
phases of Chagas disease. In these phases, the sensitivity
of the techniques depends on the varying concentration of
parasites in blood [1, 10]. For this reason, negative results
do not necessarily indicate a lack of parasites in the blood
or absence of infection. Serological diagnosis of T. cruzi
infection is more sensitive than PCR [10, 12]; all three
mothers analyzed by us had positive serology.
Figure 2 shows the detection of the parasite by immun-
oﬂuorescence. The parasite can be visualized in connective
tissue cells of the villous stroma (Figures 2(e)–2(h)). Pla-
centas from healthy, non-T. cruzi-infected, women did not
show evidence of the presence of the parasite (Figures 2(a)–
2(d)). Interestingly, parasites do not form amastigote nests
(the obligate intracellular replicative form of the parasite) as
seen in other tissues like the myocardium [13, 14]. In the
placentas of T. cruzi-infected women, only few parasites can
be visualized. The limited presence of the parasite maybe due
to a very low parasitemia present in the asymptomatic or
chronic phases of the disease. Another explanation for this4 Journal of Tropical Medicine
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Figure 2:DetectionofT.cruziinhumanplacentalchorionicvillifrominfectedmothers.Thepresenceofparasitesinvillousstromaofchorionic
villi from T. cruzi infected placentas was shown by immunoﬂuorescence, detected using mAb 25 antibodies. In (a–d), noninfected chorionic
villi (controls) are shown. Panels (a–d) and (e–h) show images of the same ﬁelds. Panels (a) and (e): phase contrast; (b) and (f): nuclear
stainingwithDAPI;(c)and(g):detectionoftheparasitebyimmunoﬂuorescence;(d)and(h):mergedimagesof(b-c)and(f-g),respectively.
Inserts show an ampliﬁed region of the detection of the parasite by immunoﬂuorescence (g-h). Bar scale (a–d): 50μm; (e–h): 25μm.
(a) (b)
Figure 3: Histopathological analysis of placentas from mothers infected with T. cruzi. Chorionic villi from T. cruzi-infected placentas
(b) show severe tissue damage compared to control villi from healthy noninfected woman (a). Detachment and disorganization of the
syncytiotrophoblast (arrow) as well as fetal connective tissue destruction of the villous stroma (arrowhead) is observed. Chorionic villi were
processed for routine histological techniques and stained with hematoxylin-eosin. Bar scale: 25μm.
fact may be the presence of a local placental antiparasitic
mechanism, like the increase of nitric oxide which has anti-
trypanosomal activity [15]. We observed the same limited
presence of the parasite in the ex vivo infected explants of
chorionic villi [6].
3.2.HistopathologicalAnalysisofPlacentasfromWomenInfec-
ted with T. cruzi. Figure 3(b) shows severe tissue disorgani-
zation and destruction of the chorionic villi from T. cruzi-
infected mothers, detachment of the syncytiotrophoblast
(arrows), and destruction of villous stroma (arrowhead). No
inﬂammatoryinﬁltrateisobservedinplacentasfrominfected
women or control placentas. The control placentas from
healthy women show an intact structure of the chorionic villi
(Figure 3(a)).
3.3. Placental Chorionic Villi from Women Infected with
T. cruzi Present Disorganization of the Extracellular Matrix.
The extracellular matrix (ECM) is the noncellular compo-
nent present in all tissues and organs and not only provides
essential physical scaﬀolding for the cellular constituents,
butalsoinitiates crucialbiochemicalandbiomechanicalcues
thatarerequiredfordiﬀerenttissuefunctions[16].TheECM
is composed of collagens, elastin, proteoglycans (including
hyaluronan), and noncollagenous glycoproteins forming a
complex, three-dimensional network among the cells of dif-
ferent tissues [17]. The non-collagenous proteins and pro-
teoglycans are highly glycosylated and especially abundant
in basal lamina [6, 18]. Several lines of evidence have
shown that T. cruzi interacts with host ECM components
producing breakdown products that play an important roleJournal of Tropical Medicine 5
(a) (b) (c)
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Figure 4: Placentas from mothers infected with T. cruzi present severe disorganization of chorionic villi ECM. Placental tissue from healthy
noninfected (a–c) and infected (d–f) women were processed for routine histochemical methods and stained with the PAS method for the
detection of glycosylated components (a, d) with the Arteta trichromic (b, e), and picrosirius red-hematoxylin (c, f) methods for collagen
histochemistry.Placentalchorionicvillifrominfectedmothersshowreducedstainingofglycosylatedmolecules(d),especiallyinbasallamina
(arrows) compared to controls (a). Samples from infected mothers also show reduced histochemical reaction for collagen in basal lamina (e)
and in villous stroma (f) compared to controls (b, c). Bar scale: 20μm.
in parasite mobilization and infectivity [6, 19]. We used PAS
reagent to analyze the non-collagenous component of the
ECM. The placentas from Chagasic women (Figure 4(d))
show a signiﬁcant decrease in PAS reactivity compared to
control tissue (Figure 4(a)). This reduced PAS reactivity is
particularly evident in basal lamina (Figure 4(d) arrows).
The principal ﬁbrous components of chorionic villi con-
nective tissue of the villous stroma are collagen ﬁbers, partic-
ularlycollagenI[5].Collagenﬁbersformthe“basicskeleton”
of the ECM three-dimensional network. We performed
two histochemical stains to analyze the collagen molecules:
arteta staining for collagen in basal laminae (Figures 4(b)
and 4(e)) and Picrosirius red-hematoxylin for collagen I
(Figures 4(c) and 4(f)). Histochemical reaction for collagen
was reduced in the placentas from mothers infected with
the parasite (Figures 4(e)–4(f)), indicating destruction or
disorganization of the collagen ﬁbers present in basal lamina
or villous stroma of the chorionic villi.
3.4. Placental Chorionic Villi from Women Infected with
T. cruzi Present Selective Disorganization of Basal Lamina.
The basal lamina is part of the placental barrier that parasites
have to cross in order to invade the fetal connective tissue of
thevillousstromacontainingfetalcapillaries.PASandArteta
histochemical stains showed alteration in this specialized
structure (Figures 4(d) and 4(e)). Collagen IV, heparan sul-
phate and ﬁbronectin are components of the basal lamina
[18]. We have previously shown that the parasite aﬀects the
immunoreactivity of heparan sulphate and collagen IV in
ex vivo infected chorionic villi explants in a parasite con-
centration-dependent manner, and that ﬁbronectin is not
aﬀected [6]. Placentas from T. cruzi-infected women show
similar results; the immunoreactivity for heparan sulphate is
loose or markedly decreased (Figure 5(d)). The immunore-
activity of collagen IV is decreased (Figure 5(e)) and no
change in this parameter can be observed for ﬁbronectin
(Figure 5(f)) with respect to placenta from healthy women.
4. Discussion
During congenital T. cruzi infection, the parasite reaches the
fetusbycrossingtheplacentalbarrier[6–8].CongenitalCha-
gas disease is a product of a complex interaction between
the maternal immune response, placental factors, and the
parasite [20].
Congenitally infected newborns develop a parasite-spe-
ciﬁc T-cell immune response comparable to that of adults
[21], as well as phenotypic and functional modiﬁcations
of their NK cells [22]. On the other hand, newborns of
T. cruzi-infected mothers are prone to produce higher levels
of proinﬂammatory cytokines in comparison to those born
to non-infected mothers [23]. From these observations,
some authors postulated that some newborns from T. cruzi-
infected mothers might naturally autocure their congenital
infection [24]. Interestingly, the placentas from women6 Journal of Tropical Medicine
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Figure 5: Placentas from mothers infected with T. cruzi present selective basal lamina disorganization in chorionic villi. Placental tissue from
control non-infected (a–c) and infected (d–f) women were immunostained for heparan sulphate (a, d), collagen IV (b, e), and ﬁbronectin
(c, f). Placental chorionic villi from infected mothers completely lost their immunoreactivity for heparan sulphate (d) and showed reduced
immunoreactivity for collagen IV (e), compared to controls (a, b). No diﬀerence in immunoreactivity for ﬁbronectin was observed between
controls and infected chorionic villi (c, f). Chorionic villi were processed for routine immunohistological techniques and counterstained
with Mayer’s hematoxylin. Bar scale: 20μm.
with asymptomatic Chagas disease analyzed by us do not
present inﬂammatory inﬁltrate. This aspect might represent
an interesting aspect of the placental infection by T. cruzi,
because of scarce invasion and/or destruction of the parasite
within placenta. The lack of inﬂammation may be due to
low parasite load in blood and tissues, characteristic of
asymptomatic and chronic phases of the disease. Thus, other
factors may also determine the capacity of the parasite to
infect the placenta or, alternatively, impair the congenital
transmission.
Parasitemia is one factor associated with the risk of con-
genital transmission of the parasite. A high parasitemia, as
can be detected in acute infection, correlates with a higher
transmission rate of around 50%. In chronic infected pa-
tients, with very low parasitemia, the transmission rate is
between 1 and 21% [25].
Recently, increasing evidence of the presence of local pla-
cental antiparasite factors has been reported. Among them,
nitric oxide synthesis in placental tissue [15]a n d“ h e a t -
sensitive” agents [26]h a v eb e e ni n v o l v e di nl o c a lp l a c e n t a l
defense mechanisms.
The ECM is another factor that should be considered
during tissue invasion and pathogen infection. The ECM is a
dynamic structure that interacts with cells and generates sig-
nals through feedback loops to control the behavior of cells.
Thus, ECM macromolecules are bioactive and modulate cel-
lular events such as adhesion, migration, proliferation, dif-
ferentiation, and survival [27]. Additionally, ECM molecules
are strictly organized, and this organization determines the
bioactivity of the ECM. Even minor alterations such as a
single amino acid substitution in a single ECM component
c a nl e a dn o to n l yt oa l t e r e dp h y s i c o c h e m i c a lp r o p e r t i e so f
tissues but also to changes in cellular phenotype and cell-
matrix interactions [17]. It has been proposed that these
changes in ECM structure and bioactivity in tissue function
ultimately lead to development of disease [17]. It has been
proposed that ECM alterations produced by T. cruzi not only
promote its motility in tissues and its entrance into cells, but
also alter the presence of cytokines and chemokines, which
in turn permit T. cruzi to modulate and escape both the
inﬂammatory response and the immune response [6, 19].
Alternatively, these changes in ECM function may be part of
localplacentaldefensemechanisms,whichcouldexplainwhy
only very few parasites can be detected in the placenta.
During tissue invasion, T. cruzi is able to interact with
diﬀerent elements of the ECM. Thus, the parasite presents
surface molecules, such as gp85 [19]a n dg p 8 3[ 28], glyco-
proteins that bind to laminin and ﬁbronectin [19, 28]a sw e l l
as to sulphated glycosaminoglicans such as heparan sulphate
[29]. The parasite can induce the expression of ECMJournal of Tropical Medicine 7
molecules or decrease their presence [19] .T h em o r eo b v i o u s
explanation for the decrease of ECM is that the parasite
destroys the ECM by secretion of proteases like cruzipain
[6, 30], which can degrade collagen I and IV [30], or by
inductionofmatrixmetalloproteases[31].However,another
possibility is that T. cruzi decreases the expression of these
molecules by modulation of signal transduction pathways or
cytoskeletonrearrangement.Probably,duringtissueinvasion
T. cruzi ﬁrst binds to molecules of the basal lamina, facilitat-
ing its internalization to the diﬀerent cells in the underlying
connective tissue. T. cruzi infection decreases ﬁbronectin
expression in cardiomyocyte culture. On the contrary, lam-
inin protein expression levels do not change, but the distri-
bution of this ECM component changes dramatically in this
type of cell culture [32]. We have shown previously that in
ex vivo infected human chorionic villi, the immunoreactivity
for heparansulphate decreases or disappears completely in a
parasite-concentration-dependent manner. Fibronectin does
not present changes in its immunoreactivity or in its distri-
butionpattern[6].Hereweconﬁrmtheseresultsinplacentas
from mothers with asymptomatic Chagas’ disease. In the
ex vivo infection of chorionic villi, the immunoractivity for
collagen IV decreases in the basal lamina between the tro-
phoblast and villous stroma, but not around fetal capillaries
[6]. In the placentas from the Chagasic women, collagen IV
immunoreactivity is decreased in both basal laminae. It is
probable that chronic exposure to the parasite during the
entire pregnancy causes a more severe change in ECM than a
24-hour challenge in ex vivo infected placental tissue.
5. Conclusion
The evidence that placentas from T. cruzi-infected women
present severe ECM alterations indicates that the parasite
induces reorganization of this tissue component in such a
way that may regulate inﬂammatory and immune responses
in the host. If this is the case, changes in placental tissue
ECM, together with the immunological status of mother and
fetus, and parasite load may determine the probability of
congenital transmission of T. cruzi.
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